Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

被引：0
|
作者：
Tran, C. [1 ]
Scott, A. [1 ]
Li, G. [1 ]
Sherman, S. [1 ]
Ear, P. H. [1 ]
Howe, J. [1 ]
机构：
[1] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
B-1
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [1] Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling
    Tran, Catherine G.
    Scott, Aaron T.
    Li, Guiying
    Sherman, Scott K.
    Ear, Po Hien
    Howe, James R.
    SURGERY, 2021, 169 (01) : 155 - 161
  • [2] Expression of somatostatin receptors in pancreatic neuroendocrine tumors
    Yada, K.
    Masuda, T.
    Hirashita, T.
    Eguchi, H.
    Iwashita, Y.
    Ogawa, T.
    Ohta, M.
    Kitano, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A146 - A146
  • [3] Efficacy of somatostatin analogues in the treatment of metastatic and unresectable pancreatic neuroendocrine tumors
    Sanchez Dominguez, G.
    Correa Cano, R.
    Pimentel, A.
    Rivera, S.
    Dip, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S140 - S140
  • [4] Relevance of somatostatin receptor expression in pancreatic neuroendocrine tumors for treatment with somatostatin analogues
    Brede, S.
    Brabant, G.
    Begum, N.
    Lehnert, H.
    Thorns, C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [5] Pancreatic neuroendocrine tumors with somatostatin expression and paraganglioma-like features
    Konukiewitz, Bjoern
    von Hornstein, Matthias
    Jesinghaus, Moritz
    Steiger, Katja
    Weichert, Wilko
    Detlefsen, Sonke
    Kasajima, Atsuko
    Kloeppel, Guenter
    HUMAN PATHOLOGY, 2020, 102 : 79 - 87
  • [6] Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs
    Fernandes, Isabel
    Pacheco, Teresa R.
    Costa, Adilia
    Santos, Ana C.
    Fernandes, Ana R.
    Santos, Mara
    Oliveira, Antonio G.
    Casimiro, Sandra
    Quintela, Antonio
    Fernandes, Afonso
    Ramos, Madalena
    Costa, Luis
    ONCOTARGETS AND THERAPY, 2012, 5 : 409 - 416
  • [7] PANCREATIC AND DUODENAL NEUROENDOCRINE TUMORS PRODUCING SOMATOSTATIN
    Milanetto, A. C.
    Veronese, E.
    Fassan, M.
    Pasquali, C.
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [8] Unexpected patterns of somatostatin receptor expression by primitive neuroendocrine tumors and their metastatic lesions
    dell'Erba, L.
    Boni, G.
    Lazzeri, E.
    Novello, M.
    Caruso, M. L.
    Ricci, S.
    Colucci, G.
    Volterrani, D.
    Mariani, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII157 - VII157
  • [9] Therapy for metastatic pancreatic neuroendocrine tumors
    Rossi, Roberta Elisa
    Massironi, Sara
    Conte, Dario
    Peracchi, Maddalena
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (01)
  • [10] Decreased UCHLI expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors
    Moore, Maureen D.
    Finnerty, Brendan
    Gray, Katherine D.
    Hoda, Rana
    Liu, Yi-Fan
    Soong, Lauren
    Beninato, Toni
    Rao, Rema
    Zarnegar, Rasa
    Fahey, Thomas J., III
    SURGERY, 2018, 163 (01) : 226 - 230
12345